Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Bevacizumab on Corneal Neovascularization
NCT00797303Phase 4Completed
- Sponsor
- Instituto de Olhos de Goiânia
- Start
- Jan 2006
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of bevacizumab in corneal neovascularization (CNV), sponsored by Instituto de Olhos de Goiânia. Started Jan 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
corneal neovascularization (CNV)
Beyond the preview
Go deeper on NCT00797303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797303.